MedTrace Logo

A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer

NCT04024358 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-03-12

No results posted yet for this study

Summary

The aim of this study is to validate both retrospectively and prospectively a newly proposed scoring system for perineural and vascular invasion in pancreatic ductal cancer and correlate it with disease free survival, early recurrence, site of recurrence, overall survival and neoadjuvant treatment.

Conditions

  • Pancreas Cancer

Sponsors & Collaborators

  • Massimo Falconi

    lead OTHER

Principal Investigators

  • Marco Schiavo Lena · IRCCS Ospedale San Raffaele

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04024358 on ClinicalTrials.gov